‘What next?’ Schumer lambasts Texas judge’s abortion pills ruling

Democratic lawmakers are doubling down on outrage against Friday's ruling that threatens access to a widely used abortion medication, saying the ruling sets a "dangerous new precedent" that could harm future medications approved by the Food and Drug Administration.

"Make no mistake, the decision could throw our country into chaos," said the Democratic Senate majority leader Chuck Schumer on a call with reporters on Saturday. "Republicans have completely eviscerated the FDA as we know it and threatened the ability of any drug on the market to avoid being prohibited.

"What could come next if some fringe radical group brings a lawsuit? Cancer drugs? Insulin? Mental health treatment?"

Mifepristone was approved for use by the FDA in 2000 and, along with a second drug called misoprostol, is the most common method for terminating a pregnancy in the US. More than half of women in the country who get abortions use the two medications.

On Friday, federal judge Matthew Kacsmaryk of Texas suspended the FDA's approval of mifepristone in a lawsuit that challenges the drug's initial approval. Kacsmaryk gave the FDA a week to appeal his ruling.

Meanwhile, a federal court in Washington state handed down a conflicting ruling that orders the FDA to not take any action that affects the drug's availability.

The president and chief executive officer of the Center for Reproductive Rights, Nancy Northrup, told reporters the Texas judge's decision could have a "devastating impact" if it goes into effect.

"If allowed to stand, it would remove mifepristone from the market in states where it's legal and exposes the lie" that states would get to decide their own abortion laws after the US supreme court eliminated federal abortion rights through their Dobbs decision last year, Northrup said. She added: "It threatens the FDA's authority over its entire drug approval process, which could severely limit the development of new drugs overall and have far-reaching repercussions on patients' access to FDA-approved medications."

Northrup emphasized that the medication is a safe and effective means of abortion and that the drug is on the World Health Organization's list of essential medicines. She also said the appeal could end up in the US supreme court within a week, if the litigation from the 2021 Texas abortion ban - which was quickly taken up by the court - is any indication.

"That's entirely possible, but abortion providers across the country are preparing and being advised on what to do if this actually goes into effect," Northrup said.

Democrats on Saturday said they support the appeal that the US justice department on Friday indicated it would file, seeking a halt to Kacsmaryk's decision. And the party is still working to get the Women's Health Protection Act passed. The legislation, introduced late last month, seeks to protect abortions on a federal measure but lacks the Republican support needed to pass.

A Democratic senator from Washington, Patty Murray, said Democrats would "put Republicans on the record every way we can so the American people know exactly who is responsible for this chaos".

"We will have this debate out in the public for everyone to see," she said.

Schumer said that Republicans have likely mostly been silent on the ruling because "they're afraid to speak out".

Beyond the justice department appeal, it is unclear what other course of action Demcrats are planning to take to combat the ruling. Schumer and Murray were asked by a reporter if there is any possibility that the federal government could take similar action to Washington state, where governor Jay Inslee announced on Tuesday that his administration would stockpile thousands of abortion pills for his constituents in anticipation of it becoming difficult to access.

"Our very first action is to make sure that this does not go into effect," Murray said. "Our most important task is to have this appealed."

Also on Saturday, more than 40 House Democrats sent Joe Biden a letter calling on the president to "use all the tools at your disposal to protect access to abortion and reproductive healthcare".

The representatives said that in addition to legal action against the ruling, the White House should defend the authority of the FDA and meet with the pharmaceutical industry to "discuss possible ramifications of an unfavorable decision regarding market access to medication abortions and the implications it will have on the [FDA] drug review process at large".